Cargando…
Emerging protein degradation strategies: expanding the scope to extracellular and membrane proteins
Classic small molecule inhibitors that directly target pathogenic proteins typically rely on the accessible binding sites to achieve prolonged occupancy and influence protein functions. The emerging targeted protein degradation (TPD) strategies exemplified by PROteolysis TArgeting Chimeras (PROTACs)...
Autores principales: | Lin, Jiayi, Jin, Jinmei, Shen, Yiwen, Zhang, Lijun, Gong, Gang, Bian, Huiting, Chen, Hongzhuan, Nagle, Dale G., Wu, Ye, Zhang, Weidong, Luan, Xin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Ivyspring International Publisher
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8344007/ https://www.ncbi.nlm.nih.gov/pubmed/34373745 http://dx.doi.org/10.7150/thno.62686 |
Ejemplares similares
-
Polymer chimera of stapled oncolytic peptide coupled with anti-PD-L1 peptide boosts immunotherapy of colorectal cancer
por: Lu, Lu, et al.
Publicado: (2022) -
The peptide PROTAC modality: a novel strategy for targeted protein ubiquitination
por: Jin, Jinmei, et al.
Publicado: (2020) -
Small-molecule PROTAC mediates targeted protein degradation to treat STAT3-dependent epithelial cancer
por: Jin, Jinmei, et al.
Publicado: (2022) -
Extracellular protein degradation via the lysosome
por: Eldeeb, Mohamed A., et al.
Publicado: (2020) -
Bruceine D inhibits HIF-1α-mediated glucose metabolism in hepatocellular carcinoma by blocking ICAT/β-catenin interaction
por: Huang, Rui, et al.
Publicado: (2021)